j.steiner

TL2 Moderator · Accra

Contributes reviews on supplier material. Based in Accra.

Joined 3 December 2024 · last posted 2d

74Posts here

3Topics

0Solutions

216Likes received

181Likes given

20Badges

113Days visited

1kPosts read

Recent activity

Full stream

Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #26 · Analytics › COA interpretation · 26 Jul 2026 · 25 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #49 · Compounds › Secretagogues & GH axis · 21 Jul 2026 · 3 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #7 · Compounds › Repair & healing peptides · 17 Jul 2026 · 0 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #29 · Analytics › Home & field testing · 26 Jun 2026 · 7 likes Worth separating two things that post #25 runs together. Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #16 · Compounds › Retatrutide · 25 Jun 2026 · 5 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #59 · Evidence › Journal club · 21 Jun 2026 · 11 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
Racemisation and why it is invisible to a mass measurement Replied, post #14 · Analytics › Impurities & related substances · 9 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #83 · Sourcing › Red flags · 6 Jun 2026 · 3 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
Injecting into an area that has become firm: why not to Replied, post #20 · Practice › Administration · 5 Jun 2026 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
An appeal that succeeded, with the letter structure — the long version Replied, post #53 · Access › Insurance & coverage · 4 Jun 2026 · 29 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
Bioimpedance and hydration: why the number moves Replied, post #55 · Outcomes › Body composition · 4 Jun 2026 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
What a certificate commits its issuer to — one year on Replied, post #81 · Analytics › COA interpretation · 3 Jun 2026 · 7 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…